{"date": "2021-12-14 12:42:41.890000+00:00", "ticker": "AMZN", "mrkt_info": {"open": 3391.35, "close": 3466.3}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-dateline\"><p>Dec 14, 2021</p></div><div class=\"tr-npp-lead\"><p>One ARK Invest exchange-traded fund run by ETF star Cathie Wood made a huge sale on Monday. This fund sold over 1,700 shares of Amazon.com Inc. ( <a href=\"https://247wallst.com/companies/amzn/\" data-type=\"url\" class=\"tr-link\" translate=\"no\">NASDAQ: AMZN</a> ), while the price of this ETF was down over 2% on the day. Note that the ETF is down a fair amount in the past year.It was ARK Next Fintech Innovation ETF ( <a href=\"https://247wallst.com/companies/arkf/\" data-type=\"url\" class=\"tr-link\" translate=\"no\">NYSEARCA: ARKF</a> ) that sold 1,794 shares of Amazon. At Monday's closing price, this would have valued this sale at $6.1 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is down around 14% in the past 12 months.Check out all of <a href=\"https://247wallst.com/investing/2021/12/13/cathie-woods-ark-invest-sells-for-12-13/\" data-type=\"url\" class=\"tr-link\" translate=\"no\">ARK Invest's Sales for Monday</a> :</p><p>Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.</p></div><div class=\"tr-npp-body\"><div class=\"story-table-container\"><table class=\"story-basic-table\"><thead><tr><th>Fund</th><th>Ticker</th><th>Name</th><th>Shares</th></tr></thead><tbody><tr><td>ARKF</td><td>AMZN</td><td>AMAZON.COM</td><td>1,794</td></tr><tr><td>ARKF</td><td>INTU</td><td>INTUIT</td><td>17,787</td></tr><tr><td>ARKF</td><td>ICE</td><td>INTERCONTINENTAL EXCHANGE</td><td>122,291</td></tr><tr><td>ARKF</td><td>FB</td><td>FACEBOOK</td><td>33,204</td></tr><tr><td>ARKG</td><td>PFE</td><td>PFIZER</td><td>155,578</td></tr><tr><td>ARKG</td><td>REGN</td><td>REGENERON PHARMACEUTICALS</td><td>12,000</td></tr><tr><td>ARKK</td><td>IOVA</td><td>IOVANCE BIOTHERAPEUTICS</td><td>100,398</td></tr><tr><td>ARKK</td><td>EDIT</td><td>EDITAS MEDICINE</td><td>202,964</td></tr><tr><td>ARKW</td><td>LPSN</td><td>LIVEPERSON</td><td>48,143</td></tr><tr><td>ARKW</td><td>SHOP</td><td>SHOPIFY</td><td>12,500</td></tr><tr><td>ARKX</td><td>BA</td><td>BOEING</td><td>10,696</td></tr></tbody></table></div><p><span><a href=\"https://247wallst.com/aerospace-defense/2021/12/14/goldman-sachs-says-3-aerospace-and-defense-stocks-may-be-the-best-offense-in-2022/\" data-type=\"url\" class=\"tr-link\" translate=\"no\">ALSO READ: Goldman Sachs Says 3 Aerospace and Defense Stocks May Be the Best Offense in 2022</a> </span></p><p>Get Our Free Investment Newsletter</p><p>The views expressed in any and all content distributed by Newstex and its re-distributors (collectively, the \"Newstex Authoritative Content\") are solely those of the respective author(s) and not necessarily the views of Newstex or its re-distributors. Stories from such authors are provided \"AS IS,\" with no warranties, and confer no rights. The material and information provided in Newstex Authoritative Content are for general information only and should not, in any respect, be relied on as professional advice. Newstex Authoritative Content is not \"read and approved\" before it is posted. Accordingly, neither Newstex nor its re-distributors make any claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained therein or linked to from such content, nor do they take responsibility for any aspect of such content. The Newstex Authoritative Content shall be construed as author-based content and commentary. Accordingly, no warranties or other guarantees are offered as to the quality of the opinions, commentary or anything else appearing in such Newstex Authoritative Content. Newstex and its re-distributors expressly reserve the right to delete stories at its and their sole discretion.</p></div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright (c) 2021 24/7 Wall St.</p></div>"}